KDNY Chinook Therapeutics, Inc.

Chinook Therapeutics is a clinical-stage biotechnology company developing precision medicines for kidney diseases. Kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems.

$15.47  +0.29 (1.91%)
As of 06/21/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/14/2015
Outstanding shares:  44,616,296
Average volume:  322,336
Market cap:   $713,860,736
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    16961L106
ISIN:        US16961L1061
Sedol:      BMWXTQ9
Valuation   (See tab for details)
PE ratio:   -6.39
PB ratio:   2.25
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy